[Changes in the immunocompetent cell system of the peripheral blood in HIV carriage] NLM AIDSLINE Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Changes in the immunocompetent cell system of the peripheral blood in HIV carriage]

Lik Sprava. 1995 Mar-Apr;(3-4):112-5. Unique Identifier : AIDSLINE MED/96417148
Karabanov VR; Markov IS; Marchenko NE

Abstract: HIV-carriage is characterized by hematological signs such as normocytosis of the general leucocyte count and deviations within normal range of values for myeloid series cells (neutrophiles, eosinophiles, basophiles). A peculiar hematological sign seen in HIV-infection is a finding of a raised content of cellular elements of mononuclear type on a hemogramme of peripheral blood and consistent decrease in the level of small T-lymphocytes against the background of substantial growth of suppressor-killer populations (large lymphocytes and lymphocyte-like mononuclears) as evidenced by a mononucleorogramme of peripheral blood, which fact provide a mechanism of antiviral protection at early stages of HIV-infection. Such changes in hemogrammes of peripheral blood, consistently found in all virus carriers, may be used in clinical settings as an early diagnostic sign of HIV-infection.
Keywords: Carrier State/BLOOD/*DIAGNOSIS English Abstract Female Human HIV Infections/BLOOD/*DIAGNOSIS *HIV-1 Leukocyte Count Leukocytes, Mononuclear/*IMMUNOLOGY Lymphocytes/*IMMUNOLOGY Male JOURNAL ARTICLEKWDcarrierstate/blood/KWDdiagnosisenglishabstractfemalehumanhivinfections/blood/KWDdiagnosisKWDhiv-1leukocytecountleukocytes,mononuclear/KWDimmunologylymphocytes/KWDimmunologymalejournalarticle
970228
M9721915

Copyright © 1997 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .